Novel Theranostic Agents with Functions of Two-Photon Imaging and Therapeutic Treatment

Keyphrases

1. Living Cells 100%
2. Alzheimer's Disease 96%
3. Near-infrared Imaging 84%
4. Fluorescent Probe 84%
5. Induced Toxicity 78%
6. Ratiometric Fluorescent Probe 72%
7. Amyloid-β Oligomers 72%
8. Lysosomal pH 66%
9. Early Detection 66%
10. Early Diagnosis 65%
11. Theranostic Agent 60%
12. Cyanine 60%
13. Alzheimer's Disease Model 60%
14. Lysosome 58%
15. APPPS1 48%
16. Dual-modal 48%
17. Two-photon 48%
18. Blood-brain Barrier 36%
19. Magnetic Resonance Imaging 36%
20. Neuroprotective Effect 36%
21. Self-aggregation 36%
22. Turn-on Fluorescence 36%
23. Emissive 36%
24. Amyloid Plaques 36%
25. Two-photon Fluorescent Probe 35%
26. Specific Probe 30%
27. Anti-Alzheimer Drugs 30%
28. Magnetic Resonance Imaging Contrast Agents 30%
29. High Spatial Resolution 30%
30. Fluorescence Imaging 30%
31. Long Wavelength 30%
32. Oligomeric 30%
33. Ratiometric 30%
34. High Selectivity 30%
35. Neuroprotection 30%
36. High Sensitivity 30%
37. Quantitative Imaging 29%
38. Acidic pH 29%
39. Photostability 27%
40. HeLa Cells 26%
41. Mitochondrial pH 24%
42. In Vivo Labeling 24%
43. Benzothiazolium 24%
44. Zero Cross 24%
45. Gadolinium-based 24%
46. Tissue Detection 24%
47. Live Cancer 24%
48. Transgenic Mouse Model 24%
49. Magnetic Nanoparticles 24%
50. Disease Treatment 24%
51. Infrared Suppression 24%
52. Living Tissue 24%
53. Therapeutic Treatment 24%
54. Theranostic Probe 24%
55. Theranostic Nanoprobe 24%
56. Ratiometric Fluorescence Imaging 24%
57. Acid pH 24%
58. Lysosome-targeting 24%
59. Neuropathology 24%
60. Alzheimer's Disease Brain 24%
61. Early Alzheimer's Disease 24%
62. Two-photon Imaging 24%
63. Imaging Tools 24%
64. Contrast Agent 24%
65. Superparamagnetic Iron Oxide Nanoparticles (SPIONs) 24%
66. NIR-II Fluorophores 24%
67. Alzheimer's Disease Detection 24%
68. Dual-modal Nanoprobe 24%
69. Dual-modal Imaging 24%
70. Brain Imaging 24%
71. Positron Emission Tomography 24%
72. Extracellular Deposits 24%
73. Low Spatial Resolution 24%
74. Imaging Magnetic Resonance 24%
75. Alzheimer's Disease Diagnosis 24%
76. Effective Monitoring 24%
77. Intracellular pH 24%
78. Nitroreductase 24%
79. Early Therapy 24%
80. Zebrafish 24%
81. Cardiac Troponin 24%
82. Fluorophore 24%
83. Non-radial 24%
84. Hypoxia Imaging 24%
85. High Quantum Yield 24%
86. Nanoprobe 24%
87. Cancer Tissue 24%
88. Cardiac Biomarkers 24%
89. Binding Affinity 24%
90. Mouse Model 24%
91. Tumor 24%
92. Neuroprotective 24%
93. Targeted Theranostics 24%
94. In Vivo Imaging 24%
95. Reactive Oxygen Species Production 24%
96. Immunomagnetic 24%
97. Aptamer 24%
98. Chromophoric 24%
99. Imaging in Living Cells 24%
100. Cancer Differentiation 24%
101. Low Abundance 24%
102. Disease Progression 24%
103. Early Intervention 24%
104. DNA Nanodevice 24%
105. Senile Plaques 24%
106. Fluoro 24%
107. Emission Spectrum 23%
108. Highly Sensitive 23%
109. Cell Behavior 18%
110. Fluorescence Enhancement 18%
111. Nanoparticles 18%
112. Inhibitory Effect 18%
113. Biological Products 16%
114. High Specificity 16%
115. Carbazole 16%
116. Low Cytotoxicity 16%
117. Cytoplasmic pH 16%
118. Physiological Processes 15%
119. Biological Systems 15%
120. Vinyl 14%
121. Benzisothiazolinone 14%
122. Imaging in Vivo 12%
123. Progression Monitoring 12%
124. Binding Potential 12%
125. Near-infrared Fluorescent Probe 12%
126. Soluble Oligomers 12%
127. Low Biotoxicity 12%
128. In Vitro Labeling 12%
129. Prodrug 12%
130. Two-photon Absorption 12%
131. Barrier Penetrability 12%
132. Neuroprotection Effect 12%
133. 2-Naphthylamine 12%
134. Acid-base Disorders 12%
135. Structural Build-up 12%
136. High-resolution Imaging 12%
137. Oxazolidine 12%
138. Exogenous Stimulation 12%
139. High-resolution Tracking 12%
140. Monitoring Disease Progression 12%
141. Targeting Capability 12%
142. Large Emission Shift 12%
143. Variation Range 12%
144. In Vivo Applications 12%
145. Minor Change 12%
146. Living Systems 12%
147. PH Modifier 12%
148. PH Changes 12%
149. PH Sensing 12%
150. Theranostics 12%
151. ROS Production 12%
152. Design Strategy 12%
153. Attenuation 12%
154. High Biocompatibility 12%
155. Autofluorescence 12%
156. Near-infrared 12%
157. Near-infrared Emission 12%
158. Solvatochromism 12%
159. Dementia 12%
160. Non-invasive Method 12%
161. Double Transgenic 12%
162. Ca2+ Influx 12%
163. New Series 12%
164. PH-sensitive 12%
165. PH Probe 12%
166. Good Stability 12%
167. Synergistic Effect 12%
168. Silica 12%
169. Novel Therapies 12%
170. Bathochromic Shift 12%
171. Double Transgenic Mice 12%
172. Binding Ability 12%
173. Biochemical Processes 12%
174. Low Toxicity 12%
175. Blood-brain Barrier Permeability 12%
176. Strong Fluorescence 12%
177. PH Variation 12%
178. Conjugated System 12%
179. Simultaneous Detection 12%
180. Systemic Administration 12%
181. High-resolution 12%
182. Disease Diagnosis 12%
183. Optical Characteristics 12%
184. Neurodegenerative 12%
185. Penetration Depth 12%
186. High pH 12%
187. Effectiveness Evaluation 12%
188. Liver Tissue 12%
189. Amyloid-β Peptide 12%
190. Hydrolytic Enzymes 10%
191. Lysosomal Targeting 10%
192. Fast Responsive 10%
193. Acid-sensing 10%
194. Biocompatible Probe 10%
195. Pathological Conditions 10%
196. Macromolecules 10%
197. Neurodegenerative Diseases 10%
198. Benzimidazole 9%
199. Pathological Process 9%
200. Acidic Organelle 9%